Intec Pharma (NTEC) Stock Forecast, Price & News

Intec Pharma (NASDAQ:NTEC) Frequently Asked Questions

How were Intec Pharma's earnings last quarter?

Intec Pharma Ltd (NASDAQ:NTEC) issued its earnings results on Monday, May, 17th. The biotechnology company reported ($3.84) earnings per share (EPS) for the quarter, missing the consensus estimate of ($3.48) by $0.36.
View Intec Pharma's earnings history.

When did Intec Pharma's stock split? How did Intec Pharma's stock split work?

Shares of Intec Pharma reverse split on Tuesday, July 27th 2021. The 1-4 reverse split was announced on Tuesday, July 27th 2021. The number of shares owned by shareholders was adjusted after the closing bell on Tuesday, July 27th 2021. An investor that had 100 shares of Intec Pharma stock prior to the reverse split would have 25 shares after the split.

Who are Intec Pharma's key executives?

Intec Pharma's management team includes the following people:

• Jeffrey A. Meckler, Vice Chairman & Chief Executive Officer
• Nir Sassi, President & Chief Financial Officer
• Michael James Newman, Director & Chief Scientific Officer
• Anna Hotovely-Salomon, Director-Clinical Affairs
• Walt A. Linscott, Chief Business Officer

Who are some of Intec Pharma's key competitors?

Some companies that are related to Intec Pharma include Acer Therapeutics (ACER), Chemomab Therapeutics (CMMB), Galecto (GLTO), IMARA (IMRA), Celyad Oncology (CYAD), Oragenics (OGEN), Oragenics (OGEN), Oncorus (ONCR), Clever Leaves (CLVR), AngioSoma (SOAN), NeuBase Therapeutics (NBSE), GlycoMimetics (GLYC), Bioxytran (BIXT), Adial Pharmaceuticals (ADIL) and Gain Therapeutics (GANX).
View all of NTEC's competitors.

What other stocks do shareholders of Intec Pharma own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Intec Pharma investors own include SCYNEXIS (SCYX), Inovio Pharmaceuticals (INO), Dynavax Technologies (DVAX), (CGC), Nabriva Therapeutics (NBRV), Onconova Therapeutics (ONTX), Viking Therapeutics (VKTX), Allena Pharmaceuticals (ALNA), T2 Biosystems (TTOO) and Acasti Pharma (ACST).

When did Intec Pharma IPO?

(NTEC) raised $30 million in an IPO on Tuesday, August 4th 2015. The company issued 5,000,000 shares at a price of $6.00 per share. Maxim Group and Roth Capital Partners served as the underwriters for the IPO.

What is Intec Pharma's stock symbol?

Intec Pharma trades on the NASDAQ under the ticker symbol "NTEC."

How much money does Intec Pharma make?

Intec Pharma has a market capitalization of $0.00. The biotechnology company earns $-14.13 million in net income (profit) each year or ($16.32) on an earnings per share basis.

How many employees does Intec Pharma have?

Intec Pharma employs 40 workers across the globe.

What is Intec Pharma's official website?

The official website for Intec Pharma is www.intecpharma.com.

How can I contact Intec Pharma?

Intec Pharma's mailing address is 12 HARTOM STREET HAR HOTZVIM, JERUSALEM L3, 777512. The biotechnology company can be reached via phone at (722) 586-4657 or via email at [email protected].